There were not any differences in the median proportion of CD45RO+ CD4+ cells between the three groups (Figure 1), but when we analyzed the median of CD4+ CD45RO+ GMF intensity we observed the lowest proportion in COVID-19(+) patients (Table 4). This evidence concerns the gene CD4 and COVID-19.